Yvette C. Terrie

Yvette C. Terrie

Yvette C. Terrie

Articles by Yvette C. Terrie

Study Shows No Clinical Benefit Observed With Atezolizumab as Adjunctive Therapy for Triple Negative Breast Cancer

Yvette C. TerrieTriple-Negative Breast Cancer | April 8, 2025

Adding atezolizumab to chemotherapy did not result in clinical benefit in patients with triple-negative breast cancer.

Study Shows That Black Patients With Metastatic Breast Cancer Tend to Experience Higher Mortality Rates Than White Patients

Yvette C. TerrieBreast Cancer News | April 6, 2025

Study finds somatic differences and lower PI3K inhibitor use in Black vs White patients with metastatic breast cancer.

Interim SERENA-6 Data: Camizestrant Significantly Improves PFS in First-Line HR+/HER2- Advanced Breast Cancer With ESR1 Mutations

Yvette C. TerrieHR Breast Cancer | April 4, 2025

Camizestrant plus CDK4/6 inhibition significantly improved PFS in HR+/HER2– advanced breast cancer with ESR1 mutations.